anmelden
Swiss All Share Index
19.854,81
PKT
+24,74
PKT
+0,12
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu Swiss All Share Index-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.10.19 | Novartis Neutral | UBS AG | |
| 24.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | ams-OSRAM Underperform | Credit Suisse Group | |
| 23.10.19 | UBS Outperform | Credit Suisse Group | |
| 23.10.19 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 23.10.19 | Novartis Neutral | Credit Suisse Group | |
| 23.10.19 | Novartis Underweight | Barclays Capital | |
| 23.10.19 | Nestlé overweight | JP Morgan Chase & Co. | |
| 23.10.19 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 23.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 23.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 23.10.19 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 22.10.19 | Roche buy | Deutsche Bank AG | |
| 22.10.19 | Novartis buy | Merrill Lynch & Co., Inc. | |
| 22.10.19 | UBS buy | Merrill Lynch & Co., Inc. | |
| 22.10.19 | Novartis buy | Jefferies & Company Inc. | |
| 22.10.19 | UBS Sector Perform | RBC Capital Markets | |
| 22.10.19 | Novartis Underweight | Morgan Stanley | |
| 22.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | UBS overweight | JP Morgan Chase & Co. | |
| 22.10.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 22.10.19 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 22.10.19 | Novartis Neutral | UBS AG | |
| 22.10.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.10.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 22.10.19 | Novartis Hold | Deutsche Bank AG | |
| 21.10.19 | Roche buy | Goldman Sachs Group Inc. | |
| 21.10.19 | Novartis Underweight | Morgan Stanley | |
| 21.10.19 | Nestlé buy | Jefferies & Company Inc. | |
| 21.10.19 | Swiss Re Outperform | Credit Suisse Group | |
| 21.10.19 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 21.10.19 | Nestlé Hold | HSBC | |
| 21.10.19 | Roche overweight | JP Morgan Chase & Co. | |
| 18.10.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.10.19 | Nestlé Hold | HSBC | |
| 18.10.19 | Swiss Re Outperform | Credit Suisse Group | |
| 18.10.19 | Nestlé buy | Baader Bank |